TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 1 | -2 | -6 | 2 | -7 | -11 | -24 | -8 |
| S | %wins | 100 | 100 | 0 | 100 | 100 | 100 | 83 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/1/17 16:25 | 11/29/17 | SNGX | Soligenix, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Essetifin Spa | L6 | H | Former 1 | S | -622 | 2.12 | 0 | -294 | -50 | 294 | M | ||||||||||||||
5/2/12 17:06 | 4/30/12 | SCLN | Sciclone Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Sigma Tau Finanziaria Spa | T | S | -33,224 | 5.25 | 2 | -6,328 | -100 | 0 | I | 39 | 46 | 41 | 27 | -5 | -7 | -4 | -1 | -2 | -6 | 2 | -7 | -11 | -24 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |